MALIGNANT TUMOR
Clinical trials for MALIGNANT TUMOR explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT TUMOR trials appear
Sign up with your email to follow new studies for MALIGNANT TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to train immune system against Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new type of cancer vaccine made from irradiated tumor and supporting cells. The goal is to see if it is safe and can help the immune system fight advanced solid tumors like osteosarcoma, pancreatic cancer, and others. About 54 participants will rece…
Matched conditions: MALIGNANT TUMOR
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
New hope for tough cancers: experimental drug JAB-8263 enters human trials
Disease control Recruiting nowThis study tests a new drug called JAB-8263 in adults with advanced solid tumors (like lung or ovarian cancer) or blood cancers (like leukemia) that have stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors. About 15…
Matched conditions: MALIGNANT TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Jacobio Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
New alpha radiation therapy offers hope for Hard-to-Treat tumors
Disease control Recruiting nowThis study is testing a new type of radiation therapy called DaRT (Diffusing Alpha Radiation Therapy) for people with malignant tumors. The main goal is to see how safe the treatment is and what side effects occur. The study will also check if the tumors shrink after treatment. A…
Matched conditions: MALIGNANT TUMOR
Phase: NA • Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
New PET scan could spot hidden diseases earlier
Diagnosis Recruiting nowThis study is testing a new type of PET imaging (Al18F-NOTA-FAPI-04) to see if it can better detect and guide treatment for cancers, heart problems, and immune diseases like hyperthyroidism. About 600 adults will receive the imaging agent and be monitored for safety and accuracy.…
Matched conditions: MALIGNANT TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Diagnosis
Last updated May 17, 2026 00:47 UTC
-
Prehab before cancer treatment: a new hope for better quality of life?
Symptom relief Recruiting nowThis study is testing whether a personalized exercise and rehabilitation program given before cancer treatment (called prehabilitation) can improve how well patients function and their overall quality of life. Researchers will enroll 60 adults with cancer who are starting care at…
Matched conditions: MALIGNANT TUMOR
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 17, 2026 00:46 UTC
-
Mind over malignancy: 2,000 patients tracked to uncover how stress shapes cancer outcomes
Knowledge-focused Recruiting nowThis study follows 2,000 adults with various cancers to see if psychological distress (like anxiety or depression) impacts how well they stick to treatment, how their tumors respond, and their overall quality of life. Participants complete questionnaires and are monitored for thr…
Matched conditions: MALIGNANT TUMOR
Sponsor: Gang Chen, MD • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
New study tests whether a 'Research Navigator' boosts cancer care and trial enrollment
Knowledge-focused Recruiting nowThis study looks at whether adding a special helper called an oncology research navigator (ORN) to standard cancer care helps patients access support services and join clinical trials. About 686 adults with new cancer appointments at UNC Medical Center will take part. The goal is…
Matched conditions: MALIGNANT TUMOR
Phase: NA • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 07, 2026 18:38 UTC